Skip to main content
FinSpry Logo
FinSpry
PPH logo
PPH
(NASDAQ)
VanEck Pharmaceutical ETF
$104.16-- (--)
Loading... - Market loading
OverviewHoldingsDividendsHistorical

PPH ETF: VanEck Pharmaceutical ETF - Price, Holdings & Analysis

VanEck Pharmaceutical ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$103.51 - $104.76
52-Week High$112.58
52-Week Low$77.67
Open$104.12
Volume173.06K
Average Volume (3M)173.06K
Assets (AUM)1.29B
Expense Ratio0.36%
Total Holdings26
Inception DateJan 31, 2000
1 Day Change0.72%
1 Month Change-5.11%
6 Month Change12.12%
YTD Change0.88%
1 Year Change17.27%
52-Week Change17.92%
5 Year Change52.50%
10 Year Change82.16%
50-Day MA$106.83
200-Day MA$96.57
RSI50.56
Stochastic %K83.35
Stochastic %D49.77
Annual Dividend$1.31
Dividend Yield1.25%
Last Dividend Ex-DateApr 4, 2026
Dividend Growth YoY-22.93%
Years Dividend Growth3

Frequently Asked Questions About VanEck Pharmaceutical ETF

What is the current price of PPH?

The latest PPH price is $104.16. The 52-week range is $77.67–$112.58. PPH has returned 17.9% over the past 52 weeks.

What is the expense ratio for PPH?

PPH's annual expense ratio is 0.36%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does PPH pay dividends?

Yes, PPH pays a 1.25% dividend yield. The last ex-dividend date was 2026-04-04. View full dividend history in the Dividends section.

What are the top holdings of PPH?

PPH's largest holdings are Eli Lilly and Company (19.2%), Novartis AG ADR (10.8%), Novartis AG (10.8%) (combined weight: 40.8%). The fund holds 26 total positions. View the complete portfolio breakdown in the Holdings section.

How does PPH compare to similar ETFs?

Compare PPH (0.36% expense ratio, $1.29B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.